By carlyo on November 4, 2014.
The ‘Nifty Fifty (times 4)’, a program of Science Spark, presented by InfoComm International, are a group of 200 noted science and engineering professionals who will fan out across the Washington, D.C. area in the 2014-2015 school year to speak about their work and careers at various middle and high schools.
Meet Nifty Fifty Speaker Karen Elkins
Vaccines against diseases such as measles, polio, and whooping cough have greatly reduced deaths and suffering. These vaccines are designed to mimic the microbes that cause the disease. When given a vaccine, the body s immune system is inspired to ramp up and fight back against that microbe. As a result, immune defenders are ready and waiting when the real thing later starts an infection.
Share this article
Share this article
OXFORD, England, May 6, 2021 /PRNewswire/ Enesi Pharma ( Enesi ), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, is delighted to report positive top-line results from a new study evaluating the immune responses generated by an ImplaVax®-enabled unit solid-dose formulation of classical swine fever (CSF) vaccine.
The results showed that a novel solid-dose ImplaVax® formulation of a recombinant E2 antigen CSF virus vaccine delivered subcutaneously using the ImplaVax® needle-free injection device generated a stronger immune response than standard liquid CSF vaccine formulations, particularly in terms of CSF virus-specific T-cell responses.
Share this article
Share this article
OXFORD, England, May 5, 2021 /PRNewswire/ Enesi Pharma ( Enesi ), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, announces it has achieved a key milestone in its project to develop needle-free thermostable unit solid-dose live vaccines with retained activity against Measles and Rubella. The project, which started in October 2019, received funding from the Bill & Melinda Gates Foundation.
The project established important proof-of-concept for ImplaVax®-enabled unit solid-dose presentations of both vaccines, demonstrating that each was thermally stable at temperatures of 40°C for three days and at 25°C for at least one month, and met key criteria for retained activity. Further longer-term stability studies are underway, and the Company is planning the immunogenicity studies needed to determine the next de
Share this article
Share this article
OXFORD, England, May 4, 2021 /PRNewswire/ Enesi Pharma ( Enesi ), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax
® technologies, announces that it has successfully developed an ImplaVax®-enabled, solid-dose recombinant H7N9 pandemic influenza vaccine and delivered proof-of-concept results in validated preclinical models.
The project
1 was conducted as part of BARDA s
Beyond the Needle initiative, which is focused on developing alternative technologies that aim to transform the paradigm of making vaccines and therapeutics easier to administer and more widely available, without the need for needles, syringes, vials, and cold-chain distribution burdens.
Honoring the Heroes of Military Medicine
HJF highlighting those involved in the fight against COVID-19.
News provided by
Share this article
Share this article
BETHESDA, Md., May 4, 2021 /PRNewswire/ The novel coronavirus, Sars-COV-2, swept across the globe in early 2020. Military, industry, private and public institutions, and individuals, all responded to the resulting COVID-19 pandemic. From donations of personal protective equipment to round-the-clock research support, the unprecedented impact on global life was met with an equally robust response. The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) honors individuals and organizations involved in this response at its annual Heroes of Military Medicine awards ceremony. With the support of the Chairman Sponsor, Health Net Federal Services, HJF recognizes individuals and organizations who have made outstanding contributions in advancing medicine for our nation s warfighters, veterans and civi